Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03056105 · ClinicalTrials.gov registry record
The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 66
- Enrollment target
NCT03056105: Completed study, sponsored by University of California, Davis.
NCT03056105 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03056105 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
The purpose of this study was to examine how participation in a 1 month intensive Insight (vipassana) Meditation retreat (a) affects biological markers of cellular aging, social affiliation, and inflammation, which are important for physical health, longevity, and behavior, and (b) to relate observed biological changes to baseline levels and changes in psychological traits, which may underlie improvements in personal adaptive functioning.
Primary Outcome
an enzyme that repairs the shortening of telomeres that occurs during aging
Interventions
- OTHER Residential Insight Meditation Retreat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2013-02-03 |
| Est. Completion | 2014-02-04 |
What the finished NCT03056105 record still lists
NCT03056105 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Residential Insight Meditation Retreat is the first listed.
NCT03056105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03056105 about?
NCT03056105 is a clinical study titled "The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat". The purpose of this study was to examine how participation in a 1 month intensive Insight (vipassana) Meditation retreat (a) affects biological markers of cellular aging, social affiliation, and inflammation, which are important for physical health, longevity, and behavior, and (b) to relate observe...
What is the current status of trial NCT03056105?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2013-02-03. Estimated completion is 2014-02-04.
What interventions are being tested in trial NCT03056105?
The interventions under investigation include: Residential Insight Meditation Retreat (OTHER).
Who is sponsoring clinical trial NCT03056105?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI